Nutritional Omics Technologies for Elucidating the Role(s) of Bioactive Food Components in Colon Cancer Prevention
|
|
- Joy Stevens
- 6 years ago
- Views:
Transcription
1 Nutritional Omics Technologies for Elucidating the Role(s) of Bioactive Food Components in Colon Cancer Prevention Nutrigenetics in Cancer Research Folate Metabolism and Colorectal Cancer 1,2 Cornelia M. Ulrich 3 Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA ABSTRACT The B vitamin folate is essential for one-carbon transfer reactions, including those related to the methylation of DNA or other substrates and nucleotide synthesis. Epidemiologic and experimental studies implicate low-folate intakes in elevated risk of colorectal neoplasia and suggest that biologic mechanisms underlying this relation include disturbances in DNA methylation patterns or adverse effects on DNA synthesis and repair. With the completion of the Human Genome Project, a vast amount of data on inherited genetic variability has become available. This genetic information can be used in studies of molecular epidemiology to provide information on multiple aspects of folate metabolism. First, studies linking polymorphisms in folate metabolism to an altered risk of cancer provide evidence for a causal link between this pathway and colorectal carcinogenesis. Second, studies on genetic characteristics can help clarify whether certain individuals may benefit from higher or lower intakes of folate or nutrients relevant to folate metabolism. Third, studies on genetic polymorphisms can generate hypotheses regarding possible biologic mechanisms that connect this pathway to carcinogenesis. Last, genetic variability in folate metabolism may predict survival after a cancer diagnosis, possibly via pharmacogenetic effects. To solve the puzzle of the folate-cancer relation, a transdisciplinary approach is needed that integrates knowledge from epidemiology, clinical studies, experimental nutrition, and mathematical modeling. This review illustrates knowledge that can be gained from molecular epidemiology in the context of nutrigenetics, and the questions that this approach can answer or raise. J. Nutr. 135: , KEY WORDS: folate polymorphism genetics colorectal cancer MTHFR TS pharmacogenetics Genetics in the omics age Multiple omics technologies are increasingly used in nutrition research and provide new tools for understanding and deciphering biologic processes. Genetics plays a role in the omics age, because it can provide complementary information to other technologies. Inherited genetic characteristics, such as the presence of a variant allele at a polymorphic locus, represent permanent, life-long characteristics of an individual. Thus, measuring the presence of an inherited mutation that 1 Presented as part of the symposium Nutritional Omics Technologies for Elucidating the Roles of Bioactive Food Components in Colon Cancer Prevention given at the 2005 Experimental Biology meeting on April 5, 2005, San Diego, CA. The symposium was sponsored by the American Society for Nutritional Sciences and in part by the Diet and Cancer and Dietary Bioactive Food Components Research Interest Sections. The proceedings are published as a supplement to The Journal of Nutrition. This supplement is the responsibility of the Guest Editors to whom the Editor of The Journal of Nutrition has delegated supervision of both technical conformity to the published regulations of The Journal of Nutrition and general oversight of the scientific merit of each article. The opinions expressed in this publication are those of the authors and are not attributable to the sponsors or the publisher, editor, or editorial board of The Journal of Nutrition. The guest editors for the supplement publication are Cindy D. Davis, National Cancer Institute, National Institutes of Health, and Norman Hord, Department of Food Science and Human Nutrition, Michigan State University. 2 This work has been supported by grants from the National Institute of Health, CA59045 (PI Potter) and CA (PI Ulrich). 3 To whom correspondence should be addressed. nulrich@fhcrc.org. alters protein function or metabolism may be considered as the measurement of a long-term exposure, potentially altering the molecular milieu both intracellularly and extracellularly. Further, many inexpensive assays are now available for characterizing an individual s genetic makeup making the measurement of genetic characteristics amenable to high-throughput technologies with large sample sizes (1). Studies on colorectal cancer a major public health problem in the developed world and folate metabolism provide an excellent example of the use of genetics and nutrigenetics in molecular epidemiology. Folate and carcinogenesis The B-vitamin folate has been investigated in regard to colorectal carcinogenesis, because lower intakes of vegetables and fruit, sources of folate, are associated with increased risk of several types of cancer (2). Today, a large body of research, both epidemiologic and experimental, illustrates the importance of this specific nutrient in colorectal carcinogenesis (3,4). Low folate intakes, or biomarkers of low-folate status, have been implicated in increased risk of colorectal cancer in a number of studies (4). However, the underlying biologic mechanisms for these associations are still not well defined. Figure 1 highlights one-carbon metabolism, including key /05 $ American Society for Nutrition. 2698
2 NUTRIGENETICS IN COLORECTAL CANCER 2699 FIGURE 1 Overview of folate-mediated one-carbon metabolism, links to methylation reactions and nucleotide synthesis [modified with permission from (19)]. THF, tetrahydrofolate; CBS, cystathionine -synthase; DHF, dihydrofolate; RFC, reduced folate carrier; hfr, human folate receptor; MTHFR, 5,10-methylenetetrahydrofolate reductase; DHFR, dihydrofolate reductase; GART, glycinamide ribonucleotide transformylase; AICARFT, 5-amino-imidazole-4-carboxamide ribonucleotide transformylase; AICAR, 5-aminoimidazole-4-carboxamide ribonucleotide; GAR, glycinamide ribonucleotide; SAM (AdoMet), S-adenosylmethionine; SAH (AdoHcy), S-adenosylhomocysteine; dump, deoxyuridine monophosphate; dtmp, deoxythymidine monophosphate; MS, methionine synthase; TS, thymidylate synthase; MT, methyltransferases; X, a variety of substrates for methylation. 4 Abbreviations used: MTHFR, methylene-tetrahydrofolate reductase; SAM, S-adenosylmethionine; THF, tetrahydrofolate; TS, thymidylate synthase. enzymes involved, and major regulatory mechanisms. Folate functions as a donor of one-carbon units and is essential for methylation reactions (including DNA methylation), as well as for nucleotide synthesis, and thus DNA synthesis and repair (5,6). Accordingly, mechanisms linking folate to carcinogenesis include adverse effects on DNA methylation both on global levels and at specific CpG sites in promoter regions as well as on DNA damage and repair capacity. DNA methylation of cytosine at CpG sites is an important regulatory mechanism for gene transcription, most likely in conjunction with chromatin changes and histone alterations (7). Dysregulation of DNA methylation patterns is a central feature of carcinogenic processes, and specifically during colon carcinogenesis, both global DNA hypomethylation and promoter-specific hypermethylation occur (8,9). S-adenosylmethionine (SAM), 4 the universal donor of methyl groups in humans (Fig. 1), provides a strong link between one-carbon metabolism and DNA methylation. Whereas the relation between dietary factors and promoter-specific hypermethylation is not well established, global DNA hypomethylation has been associated with low intakes of folate in animal models and human experimental studies (10 12). Furthermore, in a recent randomized controlled trial of patients with colorectal adenoma, supplementation with 400 g folic acid/d for 10 wk resulted in increases in global DNA methylation in both leukocytes ( 31%) and colonic mucosa ( 25%) (13). These studies illustrate that the depletion of cellular SAM can induce DNA hypomethylation, potentially resulting in the induction of proto-oncogenes (6), or causing overall genomic instability (14,15), and that supplementation may reverse these effects. In addition to effects on DNA methylation and possible subsequent DNA damage, disturbances in one-carbon metabolism are known to cause DNA damage via effects on nucleotide synthesis. In the presence of folate deficiency, uracil is misincorporated into DNA. During the repair by uracil-glycosylase, DNA strand breaks can be induced, which can cause chromosomal damage and translocations (6). This degree of genomic instability is expected to enhance carcinogenic progression. A large number of experimental studies demonstrate that these effects of folate deficiency can be observed in vitro and in vivo (6). Some studies of apparently healthy individuals have shown correlations between a low vitamin B-12 and possibly folate status and the presence of micronuclei (an indicator of chromosomal DNA damage) among healthy individuals (16,17). Further, among individuals with high DNA damage at the outset, supplementation with folic acid and vitamin B-12 was successful in reducing the number of micronuclei (16). Genetics and nutrigenetics of folate metabolism With the completion of the Human Genome Project, a vast amount of data on inherited genetic variability has become available. This genetic information can be used in studies of molecular epidemiology to provide information on multiple aspects of folate metabolism. First, studies linking polymorphisms in folate metabolism to an altered risk of cancer provide evidence for a causal link between this pathway and colorectal carcinogenesis. This is critical because high dietary intakes of folate may also correlate with other nutritional factors or health behaviors, resulting in confounding. However, genetic characteristics usually follow the rules of Mendelian randomization and thus a priori no relation between genotypes and dietary intakes or health behaviors is expected (18). Second, studies on genetic characteristics can help clarify whether certain individuals may benefit from higher or lower intakes of folate or nutrients relevant to folate metabolism. Third, studies on genetic polymorphisms can assist in elucidating biologic mechanisms that link this pathway to carcinogenesis. Last, genetic variability in folate metabolism may predict survival after a cancer diagnosis, possibly via pharmacogenetic effects. Within the folate pathway, polymorphisms with a functional impact on protein function have been described in most
3 2700 SYMPOSIUM of the key enzymes [reviewed in (19)]. Most of the molecular epidemiologic studies to date have focused on these specific candidate polymorphisms. However, an approach that investigates one individual candidate polymorphism at a time is limited in that it does not account for other genetic variants within the same biologic pathway or for other genetic polymorphisms within the same gene. Future studies should include comprehensive investigations covering genetic variability in a multitude of biologically interrelated proteins, with study sizes that are sufficient to investigate gene-gene and gene-environment interactions. Appropriate statistical tools for this pathway-based approach are necessary (20), and care needs to be taken that study designs follow epidemiologic principles (21). A candidate polymorphism approach also does not account for additional genetic variation within the same gene or in adjacent genomic regions, a limitation that can lead to associations with a particular polymorphisms that may be in linkage disequilibrium with a true causal variant. Resources such as the HapMap Project and dbsnp databases will enable researchers to address genetic variability in larger genetic regions (22). Nevertheless, the candidate polymorphism studies undertaken to date have provided us with intriguing information about the relation between folate and disease risk. To date, polymorphisms in 5,10-methylene-tetrahydrofolate reductase (MTHFR), thymidylate synthase (TS), methionine synthase, methionine synthase reductase, serine-hydroxymethyltransferase, cystathionine -synthase, methylene-tetrahydrofolate dehydrogenase, and glutamate carboxypeptidase have been investigated in relation to the risk of colorectal cancer or polyps; however, several of these have only been investigated in single studies. A comprehensive review of this literature is beyond the scope of this paper, and readers are referred elsewhere (21,23,24). Examples given below illustrate the knowledge that can be gained from molecular epidemiology, and the questions that this approach can answer or raise. Are gene-diet interactions meaningful? Genetic factors clearly play a role in carcinogenesis, as evidenced by an increased risk of cancer among a patient s family members or offspring. However, migrant studies provide unequivocal evidence that environmental factors are critical in defining cancer risk, because cancer risk assimilates within few generations to the risk of the host country (25,26). In the presence of a certain exposure, e.g., smoking, only a subset of individuals will develop cancer, arguing for interactions with other factors, including the genetic background of the host. On the molecular level, a rationale for investigating interactions is given by the paradigm that pathways or biologic systems are generally robust. Perturbations at any point within the system are unlikely to cause major harm, and thus, one may expect to see an adverse impact of genetic factors largely if the system is under stress. Hartwell (27) has described how the joint occurrence of 2 mutations in separate genes can remove some of the robustness within a pathway, arguing for the relevance of gene gene interactions. Similarly, one may expect that with a lower availability of substrate for biochemical reactions, genetic changes in enzyme function become more pronounced. In the context of folate metabolism, one can observe this relation for MTHFR. Most studies to date indicate that the variant MTHFR genotype 677TT (which encodes a thermolabile form of the enzyme with reduced in vitro function) is related to biomarkers, such as homocysteine concentrations or global DNA methylation particularly in the presence of a diet low in folate (28 31). Thus, the investigation of gene diet interactions is not only useful, but essential to gain a full understanding of the impact of genetic variation on health outcomes. Intriguingly, a modestly reduced risk of colorectal neoplasia has been observed for the MTHFR 677TT genotype (21,32), with quite consistent patterns of gene diet interactions. Studies of both adenomatous polyps, precursors of colorectal cancer, or carcinoma show that a variant MTHFR 677TT genotype is associated with a decreased risk largely in the presence of higher intakes of folate, vitamins B-6, B-12, and possibly B-2 or lower alcohol intake; however, the risk of adenoma can be increased when there is lower intake of nutrients involved in one-carbon metabolism (33 39). Thus the nutritional status of the population under study may determine which section of this interaction decrease or increase, depending on the nutritional level of the reference group is observed. Whereas several business entities are already using these limited data for marketing of genetic testing and genetically targeted nutrient supplementation (40), we need to remind ourselves that we are just at the beginning of explorations into the interactions between genetics and dietary factors, and the knowledge base is simply insufficient at this point to derive public health recommendations. Molecular epidemiology and biologic mechanisms Although molecular epidemiology does not investigate biologic mechanisms per se, findings from epidemiologic studies can provide hypotheses regarding those mechanisms. The inverse associations observed with genetically reduced MTHFR activity (e.g., a 677TT genotype) were initially attributed to a greater diversion of its substrate, 5,10-methyleneTHF, toward pyrimidine synthesis via the enzyme TS (41). A recent study by Quinlivan and colleagues (42) provides some evidence for this effect of MTHFR 677TT on thymidine synthesis. However, studies of polymorphisms in TS may point also toward an alternative explanation. The 5 -UTR of the TS gene contains polymorphic 28-bp tandem repeats; the triple repeat results in an 2- to 4-fold greater gene expression than the double repeat (43). Unexpectedly, individuals with the TS 2R/2R genotype are not at an increased risk of colorectal cancer or its precursors, yet experience a somewhat decreased risk (44 46). Furthermore, individuals with the 3R/3R genotype ( higher expression) appear more susceptible to colorectal adenoma in the presence of low-folate or high alcohol intakes, whereas no such relationships were observed for individuals with the 2R/2R genotypes (44,46). Lastly, a study of colorectal polyps that investigated the MTHFR C677T polymorphism concurrently with the TS variant, reported that individuals who had low MTHFR activity (677TT) and low TS expression (TSER 2R/2R) were unexpectedly the group at lowest risk of colorectal adenoma (44). Similar results were also observed in a colon cancer study of 1500 cases and 1900 population controls (Ulrich et al., unpublished results). These findings can generally not be reconciled with the hypothesis that a greater diversion of 5,10-methyleneTHF toward thymidine synthesis is critical for a reduction of colorectal cancer risk. Although these findings are not entirely consistent between populations, possibly because of insufficient sample sizes in some investigations, they suggest that the availability of 5,10-methyleneTHF for a third pathway, purine synthesis, may be a relevant mechanism linking folate to colorectal carcinogenesis (Fig. 1). In fact, depurination is the most common form of spontaneous DNA damage (48,49). Although endonucleases efficiently repair this damage, abasic sites exist in cellular DNA, with steady-state levels of about
4 NUTRIGENETICS IN COLORECTAL CANCER ,000 lesions per cell (49). Conceivably, purine synthesis may be the most protected pathway with respect to folate metabolism and colon carcinogenesis. Research with in vivo carbon tracers provides initial support for a relation between MTHFR genotypes and purine synthesis (42); however, this study did not investigate genotypes of TS. Further epidemiologic and experimental studies are needed to confirm or disprove this hypothesis. Beyond primary cancer prevention: secondary prevention and pharmacogenetics of folate metabolism Whereas a low-folate status may enhance carcinogenesis, the relation may be complex, in that concerns have been raised that an excessive intake can do harm (50). With folicacid fortification of food (51), folic acid intake in subsets of the population using vitamin supplements can exceed recommendations. In animal models, folate supplementation is an effective chemopreventive agent if given prior to the establishment of early lesions (e.g., aberrant crypt foci), and this activity has been attributed to adequate supplies for methylation reactions and nucleotide synthesis. However, once a preneoplastic lesion is present, folate enhances tumor growth, probably because of the dependence of rapidly dividing tissues on folate for DNA synthesis. These relations have been initially described in animal experiments (52,53), but there is now some evidence from a randomized controlled trial, demonstrating that folic acid supplementation among patients with resected adenoma may enhance the recurrence of multiple or larger adenomas (54). Preliminary results suggest that prediagnostic use of folic acid supplements is associated with shorter survival, and that genetic factors may also play a role (Ulrich et al., unpublished results). Nutrigenetics may also be relevant in this setting, in that individuals with specific genotypes may not benefit from high intakes of folic acid. For example, high intakes of folate may enhance adenoma risk among individuals with the TS 2R/2R genotype (44). Thus, the role of folic acid in cancer survivorship and the interplay with genetic factors is a critical question requiring further research. The role of folate in tumor growth is also exemplified by the use of folate antagonists in cancer treatment. Both antifolates (e.g., methotrexate), and TS inhibitors (e.g., 5-fluorouracil) target folate metabolism. Polymorphisms in key enzymes of folate metabolism can predict treatment response to these chemotherapeutics, although most studies have been too small to yield definite conclusions [for reviews see (19,55)]. The question of variable intakes of one-carbon nutrients, or use of supplements, their interaction with genetic characteristics, and possible effects on treatment outcomes, has not yet been addressed. This is a relevant concern because of the increasing use of nutritional supplements in the population, especially among cancer patients. Summary To solve the puzzle of the folate-cancer relation, a much better understanding of the combined effects of multiple genetic variants under different nutritional conditions on specific biomarkers is needed. Most fruitful to this undertaking will be a transdisciplinary approach that includes epidemiology, clinical studies, experimental nutrition, and potentially mathematical modeling. Epidemiologic studies should attempt to measure relevant biomarkers (e.g., DNA methylation) to substantiate hypotheses about the involvement of specific biologic mechanisms. Unfortunately, only a limited set of biomarkers is currently suitable for the inclusion in epidemiologic studies, both because of cost and accessibility to biologically relevant samples. Further, the presence of a tumor can alter some biomarkers, restricting their use to prospectively collected specimens. Studies in experimental nutrition, both in humans and animal models, continue to be indispensable for providing critical information about mechanisms of action of dietary components. The development of a mathematical model of the biochemical characteristics of folate-mediated one-carbon metabolism, including its links to DNA methylation and nucleotide synthesis, will permit simulations of multiple genotypes and nutritional input parameters. Such a model is currently under development, and initial results have been published (56). The ease of manipulation within a mathematical model will render it a useful tool to the research community by substantiating findings from epidemiologic studies and by suggesting specific research questions that can be addressed through laboratory investigations. ACKNOWLEDGMENT I would like to thank Clayton Hibbert for assistance with the graphics. LITERATURE CITED 1. Syvanen AC. Toward genome-wide SNP genotyping. Nat Genet. 2005;37 (Suppl): S5 S IARC Working Group. Fruits and vegetables. Lyon (France): IARC Press; Choi SW, Mason JB. Folate and carcinogenesis: an integrated scheme. J Nutr. 2000;130: Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr. 2002;132:2350S James SJ, Pogribny IP, Pogribna M, Miller BJ, Jernigan S, Melnyk S. Mechanisms of DNA damage, DNA hypomethylation, and tumor progression in the folate/methyl-deficient rat model of hepatocarcinogenesis. J Nutr. 2003;133: 3740S Duthie SJ, Narayanan S, Brand GM, Pirie L, Grant G. Impact of folate deficiency on DNA stability. J Nutr. 2002;132:2444S Laird PW. Cancer epigenetics. Hum Mol Genet 2005;14 Spec No 1: R Bariol C, Suter C, Cheong K, Ku SL, Meagher A, Hawkins N, Ward R. The relationship between hypomethylation and CpG island methylation in colorectal neoplasia. Am J Pathol. 2003;162: Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3: Rampersaud GC, Kauwell GP, Hutson AD, Cerda JJ, Bailey LB. Genomic DNA methylation decreases in response to moderate folate depletion in elderly women. Am J Clin Nutr. 2000;72: Kim YI. Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem. 1999;10: Shelnutt KP, Kauwell GP, Chapman CM, Gregory JF 3rd, Maneval DR, Browdy AA, Theriaque DW, Bailey LB. Folate status response to controlled folate intake is affected by the methylenetetrahydrofolate reductase 677C T polymorphism in young women. J Nutr. 2003;133: Pufulete M, Al-Ghnaniem R, Khushal A, Appleby P, Harris N, Gout S, Emery PW, Sanders TA. Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma. Gut. 2005;54: Eden A, Gaudet F, Waghmare A, Jaenisch R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science. 2003;300: Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, Leonhardt H, Jaenisch R. Induction of tumors in mice by genomic hypomethylation. Science. 2003;300: Fenech M, Aitken C, Rinaldi, J. Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults. Carcinogenesis. 1993;19: Fenech M, Rinaldi J. The relationship between micronuclei in human lymphocytes and plasma levels of vitamin C, vitamin E, vitamin B12 and folic acid. Carcinogenesis. 1994;15: Davey Smith G, Ebrahim S. Mendelian randomization : can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32: Ulrich CM, Robien K, Sparks R. Pharmacogenetics and folate metabolism a promising direction. Pharmacogenomics. 2002;3: Thomas DC. The need for a systematic approach to complex pathways in molecular epidemiology. Cancer Epidemiol. Biomarkers Prev. 2005;14: Little J, Sharp L, Duthie S, Narayanan S. Colon cancer and genetic variation in folate metabolism: the clinical bottom line. J Nutr. 2003;133:3758S- 66.
5 2702 SYMPOSIUM 22. The International HapMap Consortium. The International HapMap Project. Nature. 2003;426: Friso S, Choi SW. Gene-nutrient interactions in one-carbon metabolism. Curr Drug Metab. 2005;6: Ulrich, C. Genetic variability in folate-mediated one-carbon metabolism and cancer risk. In: Nutrient-gene interactions in cancer (Choi SW, Friso S, editors). CRC. Boca Raton, FL: Taylor & Francis. In press. 25. Haenszel W, Kurihara M. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst. 1968;40: McMichael AJ, Giles GG. Cancer in migrants to Australia: extending the descriptive epidemiological data. Cancer Res. 1988;48: Hartwell L. Genetics. Robust interactions. Science. 2004;303: Friso S, Choi SW, Girelli D, Mason JB, Dolnikowski GG, Bagley PJ, Olivieri O, Jacques PF, Rosenberg IH, et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA. 2002;99: Moriyama Y, Okamura T, Kajinami K, Iso H, Inazu A, Kawashiri M, Mizuno M, Takeda Y, Sakamoto Y, et al. Effects of serum B vitamins on elevated plasma homocysteine levels associated with the mutation of methylenetetrahydrofolate reductase gene in Japanese. Atherosclerosis 2002;164: Kluijtmans LA, Young IS, Boreham CA, Murray L, McMaster D, McNulty H, Strain JJ, McPartlin J, Scott JM, Whitehead AS. Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults. Blood. 2003;101: Kauwell GP, Wilsky CE, Cerda JJ, Herrlinger-Garcia K, Hutson AD, Theriaque DW, Boddie A, Rampersaud GC, Bailey LB. Methylenetetrahydrofolate reductase mutation (677C T) negatively influences plasma homocysteine response to marginal folate intake in elderly women. Metabolism. 2000;49: Houlston RS, Tomlinson IP. Polymorphisms and colorectal tumor risk. Gastroenterology. 2001;121: Chen J, Giovannucci E, Kelsey K, Rimm EB, Stampfer MJ, Colditz GA, Spiegelman D, Willett WC, Hunter DJ. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res. 1996;56: Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, Willett WC, Selhub J, Hennekens CH, Rozen R. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res. 1997;57: Ulrich CM, Kampman E, Bigler J, Schwartz SM, Chen C, Bostick R, Fosdick L, Beresford SA, Yasui Y, Potter JD. Colorectal adenomas and the C677T MTHFR polymorphism: evidence for gene-environment interaction? Cancer Epidemiol Biomarkers Prev. 1999;8: Levine AJ, Siegmund KD, Ervin CM, Diep A, Lee ER, Frankl HD, Haile RW. The methylenetetrahydrofolate reductase 677C T polymorphism and distal colorectal adenoma risk. Cancer Epidemiol. Biomarkers Prev. 2000;9: Slattery ML, Potter JD, Samowitz W, Schaffer D, Leppert M. Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev. 1999;8: Ulvik A, Evensen ET, Lien EA, Hoff G, Vollset SE, Majak BM, Ueland PM. Smoking, folate and methylenetetrahydrofolate reductase status as interactive determinants of adenomatous and hyperplastic polyps of colorectum. Am J Med Genet. 2001;101: Le Marchand L, Donlon T, Hankin JH, Kolonel LN, Wilkens LR, Seifried A. B-vitamin intake, metabolic genes, and colorectal cancer risk (United States). Cancer Causes Control. 2002;13: Williams-Jones B. Where there s a web, there s a way: commercial genetic testing and the Internet. Community Genet. 2003;6: Choi SW, Mason JB. Folate status: effects on pathways of colorectal carcinogenesis. J Nutr. 2002;132:2413S Quinlivan EP, Davis SR, Shelnutt KP, Henderson GN, Ghandour H, Shane B, Selhub J, Bailey LB, Stacpoole PW, Gregory JF 3rd. Methylenetetrahydrofolate reductase 677C- T polymorphism and folate status affect one-carbon incorporation into human DNA deoxynucleosides. J Nutr. 2005;135: Horie N, Aiba H, Oguro K, Hojo H, Takeishi K. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5 -terminal regulatory region of the human gene for thymidylate synthase. Cell Struct Funct. 1995;20: Ulrich CM, Bigler J, Bostick R, Fosdick L, Potter JD. Thymidylate synthase promoter polymorphism, interaction with folate intake, and risk of colorectal adenomas. Cancer Res. 2002;62: Chen J, Hunter DJ, Stampfer MJ, Kyte C, Chan W, Wetmur JG, Mosig R, Selhub J, Ma J. Polymorphism in the thymidylate synthase promoter enhancer region modifies the risk and survival of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2003;12: Chen J, Kyte C, Chan W, Wetmur JG, Fuchs CS, Giovannucci E. Polymorphism in the thymidylate synthase promoter enhancer region and risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2004;13: Ulrich CM, Curtin K, Potter JD, Bigler J, Caan B, Slattery ML. Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase, and risk of colon cancer. Cancer Epidemiol Biomark Preven. In press Lindahl T, Nyberg B. Rate of depurination of native deoxyribonucleic acid. Biochemistry. 1972;11: Nakamura J, Swenberg JA. Endogenous apurinic/apyrimidinic sites in genomic DNA of mammalian tissues. Cancer Res. 1999;59: Kim YI. Will mandatory folic acid fortification prevent or promote cancer? Am J Clin Nutr. 2004;80: Choumenkovitch SF, Selhub J, Wilson PW, Rader JI, Rosenberg IH, Jacques PF. Folic acid intake from fortification in United States exceeds predictions. J Nutr. 2002;132: Song J, Sohn KJ, Medline A, Ash C, Gallinger S, Kim YI. Chemopreventive effects of dietary folate on intestinal polyps in Apc /-Msh2-/- mice. Cancer Res. 2000;60: Song J, Medline A, Mason JB, Gallinger S, Kim YI. Effects of dietary folate on intestinal tumorigenesis in the apcmin mouse. Cancer Res. 2000;60: Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, McKeown-Eyssen G, Summers RW, Rothstein R, et al. A randomized trial of folic acid to prevent colorectal adenomas [abstract]. AACR 96th Annual Meeting, April 16 20, American Association of Cancer Research Proceedings. p. 1041, Abs. # Ulrich CM, Robien K, McLeod HL. Cancer pharmacogenetics: polymorphisms, pathways and beyond. Nat Rev Cancer. 2003;3: Nijhout HF, Reed MC, Budu P, Ulrich CM. A mathematical model of the folate cycle: new insights into folate homeostasis. J Biol Chem. 2004;279:
Editorial. Dietary intake and blood levels of folate, a watersoluble
Editorial Folate and Methylenetetrahydrofolate Reductase Polymorphisms: New Nutritional and Genetic Risk Factors for Pancreatic Cancer? Dietary intake and blood levels of folate, a watersoluble B vitamin
More informationNIH Public Access Author Manuscript Cancer Epidemiol Biomarkers Prev. Author manuscript; available in PMC 2012 September 1.
NIH Public Access Author Manuscript Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2011 September ; 20(9): 1912 1917. doi: 10.1158/1055-9965.EPI-10-1352. MATHEMATICAL MODELING PREDICTS
More informationFigure 1. Stepwise approach of treating patients with rheumatoid arthritis.
Establish diagnosis early Document baseline disease activity and damage Estimate prognosis Initiate therapy Begin patient education Start DMARD therapy within 3 months Consider NSAID Consider local or
More informationClinical and Pathological Significance of Epigenomic Changes in Colorectal Cancer
Clinical and Pathological Significance of Epigenomic Changes in Colorectal Cancer Shuji Ogino, M.D., Ph.D. Associate Professor of Pathology Harvard Medical School Brigham and Women s Hospital Dana-Farber
More informationOne-Carbon Metabolism and Breast Cancer
One-Carbon Metabolism and Breast Cancer A DISSERTATION SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA BY MAKI INOUE-CHOI IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE
More informationEffect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma
648 COLORECTAL CANCER Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma M Pufulete, R Al-Ghnaniem, A Khushal, P Appleby, N Harris, S Gout, P W Emery, T
More informationArve Ulvik, 1 Stein Emil Vollset, 1 Svein Hansen, 2 Randi Gislefoss, 3 Egil Jellum, 3 and Per Magne Ueland 1. Abstract.
Cancer Epidemiology, Biomarkers & Prevention 2175 Colorectal Cancer and the Methylenetetrahydrofolate Reductase 677C! T and Methionine Synthase 2756A! G Polymorphisms: A Study of 2,168 Case-Control Pairs
More informationThe Association Between Methylenetetrahydrofolate Reductase Polymorphism and Promoter Methylation in Proximal Colon Cancer
The Association Between Methylenetetrahydrofolate Reductase Polymorphism and Promoter Methylation in Proximal Colon Cancer KAEKO OYAMA, KAZUYUKI KAWAKAMI, KAZUYA MAEDA, KANAME ISHIGURO and GO WATANABE
More informationIntroduction ORIGINAL INVESTIGATION
Hum Genet (2005) 116: 347 353 DOI 10.1007/s00439-004-1243-2 ORIGINAL INVESTIGATION Carmel Kealey Æ Karen S. Brown Æ Jayne V. Woodside Ian Young Æ Liam Murray Æ Colin A. Boreham Helene McNulty Æ J. J. Strain
More informationAssessment of the Potential Health Risks of the Folic Acid Fortification Program on Acute Lymphoblastic Leukemia and Colorectal Cancer
Assessment of the Potential Health Risks of the Folic Acid Fortification Program on Acute Lymphoblastic Leukemia and Colorectal Cancer by Deborah A. Kennedy A thesis submitted in conformity with the requirements
More informationExercise prevents hyperhomocysteinemia in a folate-deficient mouse model
Graduate Theses and Dissertations Graduate College 2010 Exercise prevents hyperhomocysteinemia in a folate-deficient mouse model Joshua Charles Neuman Iowa State University Follow this and additional works
More informationCatarina Sousa Guerreiro, Bruno Carmona, Susana Gonçalves, Elisabete Carolino, Paulo Fidalgo, Miguel Brito, Carlos Nobre Leitão, and Marília Cravo
Risk of colorectal cancer associated with the C677T polymorphism in 5,10-methylenetetrahydrofolate reductase in Portuguese patients depends on the intake of methyl-donor nutrients 1 3 Catarina Sousa Guerreiro,
More informationGene polymorphisms and Folate metabolism as maternal risk factors for Down syndrome child
Nutrition is a fundamental pillar of human life, health and development across the entire life span. From the earliest stages of fetal development, at birth, through infancy, childhood, adolescence and
More informationThe silence of the genes: clinical applications of (colorectal) cancer epigenetics
The silence of the genes: clinical applications of (colorectal) cancer epigenetics Manon van Engeland, PhD Dept. of Pathology GROW - School for Oncology & Developmental Biology Maastricht University Medical
More informationTITLE: Folate and breast cancer: role of intake, blood levels, and Metabolic gene polymorphisms
AD Award Number: DAMD17-02-1-0606 TITLE: Folate and breast cancer: role of intake, blood levels, and Metabolic gene polymorphisms PRINCIPAL INVESTIGATOR: Martha J. Shrubsole, Ph.D. CONTRACTING ORGANIZATION:
More informationKim Robien, 1,5 Jeannette Bigler, 1 Yutaka Yasui, 6 John D. Potter, 1,4 Paul Martin, 2 Rainer Storb, 2 Cornelia M. Ulrich 1,3,4
Biology of Blood and Marrow Transplantation 12:973-980 (2006) 2006 American Society for Blood and Marrow Transplantation 1083-8791/06/1209-0001$32.00/0 doi:10.1016/j.bbmt.2006.05.016 Methylenetetrahydrofolate
More informationCANCER PHARMACOGENETICS: POLYMORPHISMS, PATHWAYS AND BEYOND
CANCER PHARMACOGENETICS: POLYMORPHISMS, PATHWAYS AND BEYOND Cornelia M. Ulrich*, Kim Robien* and Howard L. McLeod Inherited genetic variations can affect a patient s response to chemotherapeutic agents
More informationTHEORY OF MUTAGENESIS, CANCEROGENESIS, AND PREVENTION OF CANCER
Trakia Journal of Sciences, Vol. 3, No. 3, pp 55-59, 2005 Copyright 2005 Trakia University Available online at: http://www.uni-sz.bg ISSN 1312-1723 Hypothesis THEORY OF MUTAGENESIS, CANCEROGENESIS, AND
More informationThe Role of Observational Studies. Edward Giovannucci, MD, ScD Departments of Nutrition and Epidemiology
The Role of Observational Studies Edward Giovannucci, MD, ScD Departments of Nutrition and Epidemiology Disclosure Information As required, I would like to report that I have no financial relationships
More informationUracil misincorporation into DNA and folic acid supplementation 1 3
Uracil misincorporation into DNA and folic acid supplementation 1 3 Aditi Hazra, Jacob Selhub, Wei-Hsun Chao, Per Magne Ueland, David J Hunter, and John A Baron ABSTRACT Background: Folate deficiency decreases
More informationTHE ROLE OF B-VITAMINS GENE INTERACTIONS IN COLORECTAL CARCINOGENESIS A MOLECULAR EPIDEMIOLOGICAL APPROACH
THE ROLE OF B-VITAMINS GENE INTERACTIONS IN COLORECTAL CARCINOGENESIS A MOLECULAR EPIDEMIOLOGICAL APPROACH Promotor Prof. dr. ir. F.J. Kok Hoogleraar Voeding en Gezondheid Wageningen Universiteit Co-promotoren
More informationOriginal Article Methylenetetrahydrofolate Reductase C677T Gene Polymorphism in Osteosarcoma and Chondrosarcoma Patients
Original Article Methylenetetrahydrofolate Reductase C677T Gene Polymorphism in Osteosarcoma and Chondrosarcoma Patients (osteosarcoma / chondrosarcoma / MTHFR / polymorphism) H. OZGER 1, O. KILICOGLU
More informationAdvanced Methylation Detoxification Profile
Page: 1 of 6 Pages Methylation Detoxification Cycle: One or more mutations present: Enzyme activity will be mildly to moderately reduced (see detailed report)* No mutations present: Normal enzyme activity*
More informationA meta-analysis of MTRR A66G polymorphism and colorectal cancer susceptibility
JBUON 2015; 20(3): 918-922 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE A meta-analysis of MTRR A66G polymorphism and colorectal cancer susceptibility
More informationPolymorphisms of 5,10-methylenetetrahydrofolate reductase and thymidylate synthase,
Polymorphisms of,-methylenetetrahydrofolate reductase and thymidylate synthase, dietary folate intake, and the risk of leukemia in adults Ping Liu 1, Min Zhang 1,, Xing Xie, Jie Jin, and C D Arcy J Holman
More informationPre-Diagnostic Leukocyte Genomic DNA Methylation and the Risk of Colorectal Cancer in Women
Pre-Diagnostic Leukocyte Genomic DNA Methylation and the Risk of Colorectal Cancer in Women The Harvard community has made this article openly available. Please share how this access benefits you. Your
More informationOriginal Article Candidate pathway polymorphisms in one-carbon metabolism and risk of rectal tumor mutations
Int J Mol Epidemiol Genet 2011;2(1):1-8 www.ijmeg.org /ISSN1948-1756/IJMEG1009003 Original Article Candidate pathway polymorphisms in one-carbon metabolism and risk of rectal tumor mutations Karen Curtin,
More informationVitamin B 6 Intake, Alcohol Consumption, and Colorectal Cancer: A Longitudinal Population-Based Cohort of Women
GASTROENTEROLOGY 2005;128:1830 1837 Vitamin B 6 Intake, Alcohol Consumption, and Colorectal Cancer: A Longitudinal Population-Based Cohort of Women SUSANNA C. LARSSON,* EDWARD GIOVANNUCCI, and ALICJA WOLK*
More informationFolate intake and bowel cancer risk
Genes Nutr (2009) 4:173 178 DOI 10.1007/s12263-009-0126-5 REVIEW Folate intake and bowel cancer risk John C. Mathers Received: 8 May 2009 / Accepted: 14 May 2009 / Published online: 5 June 2009 Ó Springer-Verlag
More informationIdentification and Validation of Biomarkers in Disease States
Identification and Validation of Biomarkers in Disease States Patrick J. Stover, PhD Vice Chancellor and Dean for Agriculture and Life Sciences Disclosures AFFILIATION/FINANCIAL INTERESTS (prior 12 months)
More informationWill mandatory folic acid fortification prevent or promote cancer? 1 3
Commentary Will mandatory folic acid fortification prevent or promote cancer? 1 3 Young-In Kim ABSTRACT An overwhelming body of evidence for a protective effect of periconceptional folic acid supplementation
More informationEFFECT OF THE METHYLENETETRAHYDROFOLATE REDUCTASE 677C T POLYMORPHISM ON FOLATE STATUS AND DNA METHYLATION RESPONSE IN YOUNG WOMEN
EFFECT OF THE METHYLENETETRAHYDROFOLATE REDUCTASE 677C T POLYMORPHISM ON FOLATE STATUS AND DNA METHYLATION RESPONSE IN YOUNG WOMEN By KARLA PAGÁN SHELNUTT A DISSERTATION PRESENTED TO THE GRADUATE SCHOOL
More informationPancreaticobiliary Cancers With Deficient Methylenetetrahydrofolate Reductase Genotypes
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:752 760 Pancreaticobiliary Cancers With Deficient Methylenetetrahydrofolate Reductase Genotypes HIROYUKI MATSUBAYASHI,*, HALCYON G. SKINNER,*, CHRISTINE
More informationHigh Blood Pressure in Irish Adults
High Blood Pressure in Irish Adults Preliminary findings and lessons learned from two JINGO cohorts Helene McNulty Northern Ireland Centre for Food and Health (NICHE) University of Ulster Mortality due
More informationClinical utility of polymorphisms in one-carbon metabolism for breast cancer risk prediction
J M e d A l l i e d S c i 2 0 1 1 ; 1 ( 1 ) : 0 7-13 w w w. j m a s. i n P r i n t I S S N : 2 2 3 1 1696 O n l i n e I S S N : 2231 1 7 0 X Journal of M e d i cal & Allied Sciences Original article Clinical
More informationThymidylate synthase enhancer region polymorphism not related to susceptibility to acute lymphoblastic leukemia in the Kashmir population
Thymidylate synthase enhancer region polymorphism not related to susceptibility to acute lymphoblastic leukemia in the Kashmir population F.H. Nazki 1, A. Masood 1, M.A. Banday 2, A. Bhat 1 and B.A. Ganai
More informationAberrant DNA methylation of MGMT and hmlh1 genes in prediction of gastric cancer
Aberrant DNA methylation of MGMT and hmlh1 genes in prediction of gastric cancer J. Jin 1,2, L. Xie 2, C.H. Xie 1 and Y.F. Zhou 1 1 Department of Radiation & Medical Oncology, Zhongnan Hospital of Wuhan
More informationINFLUENCE OF B-VITAMINS ON ONE-CARBON METABOLISM AND ASSOCIATIONS WITH CANCER RISK AND REPRODUCTIVE STATE. A Dissertation
INFLUENCE OF B-VITAMINS ON ONE-CARBON METABOLISM AND ASSOCIATIONS WITH CANCER RISK AND REPRODUCTIVE STATE A Dissertation Presented to the Faculty of the Graduate School of Cornell University In Partial
More informationVitamins B 2,B 6, and B 12 and Risk of New Colorectal Adenomas in a Randomized Trial of Aspirin Use and Folic Acid Supplementation
2136 Vitamins B 2,B 6, and B 12 and Ris of New Colorectal Adenomas in a Randomized Trial of Aspirin Use and Folic Acid Supplementation Jane C. Figueiredo, 1 A. Joan Levine, 1 Maria V. Grau, 2 Øivind Midttun,
More informationWhy Use Genetic Testing in Practice?
Pure Encapsulations is committed to producing the most complete line of research-based nutritional supplements. Available through health professionals, finished products are pure and hypoallergenic to
More informationRELATIVE CONTRIBUTION OF FOOD FOLATE AND FOLIC ACID TO INTAKE AND STATUS OF YOUNG MEN AND WOMEN
RELATIVE CONTRIBUTION OF FOOD FOLATE AND FOLIC ACID TO INTAKE AND STATUS OF YOUNG MEN AND WOMEN By MELANIE LYN GRABIANOWSKI A THESIS PRESENTED TO THE GRADUATE SCHOOL OF THE UNIVERSITY OF FLORIDA IN PARTIAL
More informationPolymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia
NEOPLASIA Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia Christine F. Skibola, Martyn T. Smith, Alan Hubbard, Barry Shane,
More informationPrognostic Significance of the Polymorphisms in Thymidylate Synthase and Methylenetetrahydrofolate Reductase Gene in Lung Cancer
Prognostic Significance of the Polymorphisms in Thymidylate Synthase and Methylenetetrahydrofolate Reductase Gene in Lung Cancer AKIRA TAKEHARA, KAZUYUKI KAWAKAMI, NAOHIRO OHTA, KAEKO OYAMA, YASUHIKO OTA,
More informationThis electronic thesis or dissertation has been downloaded from the King s Research Portal at
This electronic thesis or dissertation has been downloaded from the King s Research Portal at https://kclpure.kcl.ac.uk/portal/ The influence of the MTHFR C677T genotype and folate status on genomic DNA
More informationFolic Acid and Neural Tube Defects. Rachel Leah Feinstein
Folic Acid and Neural Tube Defects Rachel Leah Feinstein Neural tube defects (NTD) are the most common types of birth defects. Research shows that folic acid taken periconceptionally greatly reduces the
More informationTrans-HHS Workshop: Diet, DNA Methylation Processes and Health
Trans-HHS Workshop: Diet, DNA Methylation Processes and Health Gene-Nutrient Interactions and DNA Methylation 1,2 Simonetta Friso 3 and Sang-Woon Choi Vitamin Metabolism Laboratory, Jean Mayer U.S. Department
More information9 Metabolic trigger: control of methionine metabolism
9 Metabolic trigger: control of methionine metabolism M.V. Martinov 1,V.M.Vitvitsky 1,E.V.Mosharov 2,R.Banerjee 2,F.I.Ataullakhanov 1 1 National Research Center for Hematology, Moscow, Russia 125167 2
More informationOne-Carbon Metabolism and Prostate Cancer Risk: Prospective Investigation of Seven Circulating B Vitamins and Metabolites
1538 One-Carbon Metabolism and Prostate Cancer Risk: Prospective Investigation of Seven Circulating B Vitamins and Metabolites Mattias Johansson, 1,2 Bethany Van Guelpen, 3 Stein Emil Vollset, 6 Johan
More informationRelationship between genetic polymorphisms of methylenetetrahydrofolate reductase and breast cancer chemotherapy response
Relationship between genetic polymorphisms of methylenetetrahydrofolate reductase and breast cancer chemotherapy response L. Yang*, X.W. Wang*, L.P. Zhu, H.L. Wang, B. Wang, T. Wu, Q. Zhao, D.L.X.T. JinSiHan
More informationMETABOLIC MECHANISMS UNDERLYING FOLATE-RESPONSIVE DEVELOPMENTAL ANOMALIES
METABOLIC MECHANISMS UNDERLYING FOLATE-RESPONSIVE DEVELOPMENTAL ANOMALIES A Dissertation Presented to the Faculty of the Graduate School of Cornell University In Partial Fulfillment of the Requirements
More informationHuman Genetics 542 Winter 2018 Syllabus
Human Genetics 542 Winter 2018 Syllabus Monday, Wednesday, and Friday 9 10 a.m. 5915 Buhl Course Director: Tony Antonellis Jan 3 rd Wed Mapping disease genes I: inheritance patterns and linkage analysis
More informationMultistep nature of cancer development. Cancer genes
Multistep nature of cancer development Phenotypic progression loss of control over cell growth/death (neoplasm) invasiveness (carcinoma) distal spread (metastatic tumor) Genetic progression multiple genetic
More informationI) Development: tissue differentiation and timing II) Whole Chromosome Regulation
Epigenesis: Gene Regulation Epigenesis : Gene Regulation I) Development: tissue differentiation and timing II) Whole Chromosome Regulation (X chromosome inactivation or Lyonization) III) Regulation during
More informationHigher folate intake 1 and blood folate concentrations 2 4
GASTROENTEROLOGY 2006;131:1706 1716 Dietary Factors and Biomarkers Involved in the Methylenetetrahydrofolate Reductase Genotype Colorectal Adenoma Pathway MARÍA ELENA MARTÍNEZ,*, PATRICIA THOMPSON*, ELIZABETH
More informationRisk of colorectal cancer associated with the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in the Kashmiri population
Risk of colorectal cancer associated with the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in the Kashmiri population A.S. Sameer 1,2, Z.A. Shah 1, S. Nissar 1, S. Mudassar 2 and M.A.
More informationSHORT REPORT INCREASING COLORECTAL CANCER INCIDENCE RATES IN JAPAN
Int. J. Cancer: 109, 777 781 (2004) 2004 Wiley-Liss, Inc. Publication of the International Union Against Cancer SHORT REPORT INCREASING COLORECTAL CANCER INCIDENCE RATES IN JAPAN Hoi-Yan YIU, Alice S.
More informationHuman Genetics 542 Winter 2017 Syllabus
Human Genetics 542 Winter 2017 Syllabus Monday, Wednesday, and Friday 9 10 a.m. 5915 Buhl Course Director: Tony Antonellis Module I: Mapping and characterizing simple genetic diseases Jan 4 th Wed Mapping
More informationEpigenetics: How Nutrients Affect Gene Expression.
Epigenetics: How Nutrients Affect Gene Expression. David Heber, MD, PhD, FACP, FASN Professor Emeritus of Medicine and Public Health and Founding Director, UCLA Center for Human Nutrition David Geffen
More informationImpact of FPGS and GGH SNPs on Plasma Folate and Homocysteine Levels in the Singapore Chinese Health Study
Impact of FPGS and GGH SNPs on Plasma Folate and Homocysteine Levels in the Singapore Chinese Health Study A THESIS SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA BY Sarah
More informationBreast Cancer Risk Associated with Multigenotypic Polymorphisms in Folate-metabolizing Genes: A Nested Case-control Study in Taiwan
Breast Cancer Risk Associated with Multigenotypic Polymorphisms in Folate-metabolizing Genes: A Nested Case-control Study in Taiwan CHENG-PING YU 1, MEI-HSUAN WU 2, YU-CHING CHOU 3, TSAN YANG 4, SAN-LIN
More informationRelative Distribution of Folate Species Is Associated with Global DNA Methylation in Human Colorectal Mucosa
Research Article Cancer Prevention Research Relative Distribution of Folate Species Is Associated with Global DNA Methylation in Human Colorectal Mucosa Jia Liu 1, Luke B. Hesson 1, Alan P. Meagher 3,
More informationRESEARCH COMMUNICATION
DOI:http://dx.doi.org/10.7314/APJCP.2012.13.2.647 RESEARCH COMMUNICATION Folate Intake, Methylenetetrahydrofolate Reductase Polymorphisms in Association with the Prognosis of Esophageal Squamous Cell Carcinoma
More informationInformation. Marie Caudill. Web Bio. Biography. Professional. Biographical Statement
Marie Caudill Information Biography Web Bio Biographical Statement Dr. Marie Caudill received her PhD degree in Nutritional Sciences from the University of Florida in 1997. Shortly thereafter she became
More informationChallenges and Opportunities with Rapidly-Changing Biomedical Technologies:
Challenges and Opportunities with Rapidly-Changing Biomedical Technologies: Insights from Genetic Testing for Colorectal Cancer 2016 CADTH Symposium Joanne Kim, M.Sc., Ph.D. 1 Disclosure The views expressed
More informationBrietta M Oaks, Kevin W Dodd, Cari L Meinhold, Li Jiao, Timothy R Church, and Rachael Z Stolzenberg-Solomon
Folate intake, post folic acid grain fortification, and pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial 1 3 Brietta M Oaks, Kevin W Dodd, Cari L Meinhold, Li
More informationIOM DRI Research Synthesis Workshop June 7-8, 2006
Discussion of Research Recommendations: Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Dietary Reference Intake Research Synthesis Workshop DRI Report on B
More informationAbstract. KEY WORDS: epigenetics, DNA methylation, histone modification, one-carbon metabolism, stem cell aging, anti-aging medicine
Glycative Stress Research Online edition : ISSN 2188-3610 Print edition : ISSN 2188-3602 Received : May 17, 2018 Accepted : July 18, 2018 Published online : September 30, 2018 doi:10.24659/gsr.5.3_129
More informationOestrogen replacement therapy reduces total plasma homocysteine and enhances genomic DNA methylation in postmenopausal women
British Journal of Nutrition (2007), 97, 617 621 q The Authors 2007 DOI: 10.1017/S0007114507433013 Oestrogen replacement therapy reduces total plasma homocysteine and enhances genomic DNA methylation in
More informationNutrition Science 7 Policy Folic Acid Fortification
Nutrition Science 7 Policy Folic Acid Fortification November 2007: 504 511 Folic Acid Fortification and Supplementation Good for Some but Not So Good for Others Young-In Kim, MD, FRCP(C) Evidence has established
More informationPharmacogenetics in: Primary Care. Bradley T. Wajda D.O.
Pharmacogenetics in: Primary Care Bradley T. Wajda D.O. Pharmacogenomics Defined Pharmacogenomics uses information about a person s genetic makeup, or genome, to choose the drugs and drug doses that are
More informationGenetic variation of folate-mediated one-carbon transfer pathway predicts susceptibility to choline deficiency in humans
Genetic variation of folate-mediated one-carbon transfer pathway predicts susceptibility to choline deficiency in humans Martin Kohlmeier, Kerry-Ann da Costa, Leslie M. Fischer, and Steven H. Zeisel* Department
More informationMultivitamin use and colon cancer mortality in the Cancer Prevention Study II cohort (United States)
Cancer Causes and Control 12: 927 934, 2001. 927 Ó 2001 Kluwer Academic Publishers. Printed in the Netherlands. Multivitamin use and colon cancer mortality in the Cancer Prevention Study II cohort (United
More informationOne-Carbon Metabolism, MTHFR Polymorphisms, and Risk of Breast Cancer
Research Article One-Carbon Metabolism, MTHFR Polymorphisms, and Risk of Breast Cancer Jia Chen, 1 Marilie D. Gammon, 3 Wendy Chan, 1 Caroline Palomeque, 1 James G. Wetmur, 2 Geoffrey C. Kabat, 4 Susan
More informationNo Effect of Folic Acid Supplementation on Global DNA Methylation in Men and Women with Moderately Elevated Homocysteine
No Effect of Folic Acid Supplementation on Global DNA Methylation in Men and Women with Moderately Elevated Homocysteine Audrey Y. Jung 1 *, Yvo Smulders 2,3, Petra Verhoef 4,5,6, Frans J. Kok 4, Henk
More informationEFFECT OF FOLATE AND VITAMIN B12 STATUS AND RELATED GENETIC POLYMORPHISMS ON CONGENITAL HEART DEFECT RISK: A PILOT STUDY
EFFECT OF FOLATE AND VITAMIN B12 STATUS AND RELATED GENETIC POLYMORPHISMS ON CONGENITAL HEART DEFECT RISK: A PILOT STUDY By YOUNIS ALI SALMEAN A THESIS PRESENTED TO THE GRADUATE SCHOOL OF THE UNIVERSITY
More informationDESPITE MEDICAL AND SURgical
ORIGINAL ARTICLE Plasma Homocysteine, Folate, and Vitamin B 12 Levels in Patients With Laryngeal Cancer Andrea Nacci, MD; Iacopo Dallan, MD; Luca Bruschini, MD; Antonio Claudio Traino, PhD; Erica Panicucci,
More informationEffect Of Dietary Folate Restriction On Colon Carcinogenesis In Dna Polymerase β Haploinsufficient Mice
Wayne State University Wayne State University Dissertations 1-1-2010 Effect Of Dietary Folate Restriction On Colon Carcinogenesis In Dna Polymerase β Haploinsufficient Mice Lisa F. Ventrella Lucente Wayne
More informationCOMPARATIVE IN VITRO STUDIES OF FOLIC ACID VERSUS 5-METHYLTETRAHYDROFOLATE SUPPLEMENTATION IN HUMAN COLORECTAL CANCER CELLS
COMPARATIVE IN VITRO STUDIES OF FOLIC ACID VERSUS 5-METHYLTETRAHYDROFOLATE SUPPLEMENTATION IN HUMAN COLORECTAL CANCER CELLS by Hea Jin Cheon A thesis submitted in conformity with the requirements for the
More informationLOW FOLATE INTAKE HAS INcreased
ORIGINAL CONTRIBUTION A Prospective Study of Folate Intake and the Risk of Breast Cancer Shumin Zhang, MD, ScD David J. Hunter, MBBS, ScD Susan E. Hankinson, ScD Edward L. Giovannucci, MD, ScD Bernard
More informationRole of vitamin D and folate towards the genetic potential in early life and adult phenotypes
Role of vitamin D and folate towards the genetic potential in early life and adult phenotypes Emeritus Professor Khor Geok Lin Universiti Putra Malaysia Jakarta 13 th November, 2016 The author declares
More informationThe lymphoma-associated NPM-ALK oncogene elicits a p16ink4a/prb-dependent tumor-suppressive pathway. Blood Jun 16;117(24):
DNA Sequencing Publications Standard Sequencing 1 Carro MS et al. DEK Expression is controlled by E2F and deregulated in diverse tumor types. Cell Cycle. 2006 Jun;5(11) 2 Lassandro L et al. The DNA sequence
More information!!"#$%&'#()*+,-).(&"/+0&'12'
LAB #: Sample Report PATIENT: Sample Patient ID: SEX: Female DOB: 01/01/1985 AGE: 33 CLIENT #: 12345 DOCTOR: Sample Doctor Doctors Data Inc 3755 Illinois Ave St. Charles, IL 60174 U.S.A.!!"#$%&'#()*+,-).(&"/+0&'12'
More informationAssociation of Methylenetetrahydrofolate reductase (MTHFR 677C>T) polymorphisms with Ovarian Malignancy in women of Northern India
214 Association of Methylenetetrahydrofolate reductase (MTHFR 677C>T) polymorphisms with Ovarian Malignancy in women of Northern India Authors:, Rinki Kumari 1, Anamika Tiwari, Aruna Agrwal, G.P.I. Singh,
More informationThe Role of Host: Genetic Variation
The Role of Host: Genetic Variation Patrick J. Stover, PhD The Janet and Gordon Lankton Professor of Nutrition Director, Division of Nutritional Sciences, Cornell University Dietary Requirements are Complex
More informationGENOME-WIDE STUDIES OF GENE-DIETARY INTERACTIONS AND COLORECTAL CANCER RISK
GENOME-WIDE STUDIES OF GENE-DIETARY INTERACTIONS AND COLORECTAL CANCER RISK Jane Figueiredo, Ph.D. Keck School of Medicine University of Southern California Diet & Colorectal Cancer (CRC) CRC is one of
More informationOverview of Evidence for Impact of Flour Fortification with Folic Acid
Overview of Evidence for Impact of Flour Fortification with Folic Acid Helene McNulty PhD RD Northern Ireland Centre for Food and Health (NICHE) University of Ulster Impact of Flour Fortification with
More informationFolic Acid and vitamin B12
Folic Acid and vitamin B12 ILOs: by the end of this lecture, you will be able to: 1. Understand that vitamins are crucial nutrients that are important to health. 2. Know that folic acid and vitamin B12
More informationMasterclass Report Diet and Cancer: From Prevention to Survival 1-3 October 2014 Wageningen, the Netherlands
Masterclass Report Diet and Cancer: From Prevention to Survival 1-3 October 2014 Wageningen, the Netherlands 1. Introduction & background to the Masterclass On 1 3 October 2014, international experts and
More informationThis review is contributed by Professor Helene McNulty RD and Dr Mary Ward RD from the University of Ulster, Northern Ireland.
1.1.1 Folate This review is contributed by Professor Helene McNulty RD and Dr Mary Ward RD from the University of Ulster, Northern Ireland. 1.1.1.1 Summary In recent years there has been much interest
More informationLower Specific Micronutrient Intake in Colorectal Cancer Patients with Tumors Presenting Promoter Hypermethylation in p16 INK4a, p14 ARF and hmlh1
Lower Specific Micronutrient Intake in Colorectal Cancer Patients with Tumors Presenting Promoter Hypermethylation in p16 INK4a, p14 ARF and hmlh1 SERGI MAS 1, M. JOSE LAFUENTE 1, ANNA CRESCENTI 1, MANUEL
More informationNeli Ulrich, MS, PhD Huntsman Cancer Institute, Salt Lake City Using Genetics and Metabolomics to Advance Precision Prevention
Neli Ulrich, MS, PhD Huntsman Cancer Institute, Salt Lake City Using Genetics and Metabolomics to Advance Precision Prevention February 3-5, 2016 Lansdowne Resort, Leesburg, VA Three Highlights Aspirin
More informationEach Tablet Contains: Supportive Function: When is Methyl Renew helpful? Clinical Applications/Research: Methylation DNA Methylation
methyl renew Each Tablet Contains: Niacin (as niacinamide) 20 mg, Folate (as L-5-Methyltetrahydrofolate) 500 mcg, Vitamin B-12 (as methylcobalamin) 500 mcg, Biotin 2000 mcg. Proprietary blend 415 mg* of:
More informationEffect of food fortification on folic acid intake in the United States 1 3
Effect of food fortification on folic acid intake in the United States 1 3 Eoin P Quinlivan and Jesse F Gregory III See corresponding editorial on page 8. ABSTRACT Background: The addition of folic acid
More informationMandatory fortification of flour with folic acid
Mandatory fortification of flour with folic acid A brief update March 2014 A. David Smith and Helga Refsum, Universities of Oxford and Oslo For earlier more detailed reports see: Is folic acid good for
More informationTitle: DNA repair gene polymorphisms and risk of chronic atrophic gastritis: a case-control study
Author's response to reviews Title: DNA repair gene polymorphisms and risk of chronic atrophic gastritis: a case-control study Authors: Bernd Frank (b.frank@dkfz.de) Heiko Müller (h.mueller@dkfz.de) Melanie
More informationTumor suppressor genes D R. S H O S S E I N I - A S L
Tumor suppressor genes 1 D R. S H O S S E I N I - A S L What is a Tumor Suppressor Gene? 2 A tumor suppressor gene is a type of cancer gene that is created by loss-of function mutations. In contrast to
More informationThe Role of Mitochondrial Folate Enzymes in Cancer. Aoife MacCooey
The Role of Mitochondrial Folate Enzymes in Cancer Aoife MacCooey MSc 2015 The Role of Mitochondrial Folate Enzymes in Cancer Aoife MacCooey B.Sc. Supervisor: Dr Anne Parle-McDermott School of Biotechnology,
More informationMetabolic Dr Elizabeth Mumper
MINDD Forum General Session Metabolic Elizabeth Mumper, MD Director of Medical Education Autism Research Institute May 2009 Vicious Cycles Food sensitivities Gut inflammation Malabsorption oxidative stress
More informationMethylation. Taking the guesswork out of diagnosis. Proper functioning of the methylation cycle helps to reduce the risk of:
Methylation The methylation cycle is a biochemical pathway that manages or contributes to a wide range of crucial bodily functions. Methylation is not just one specific reaction, there are hundreds of
More informationDetox and Methylation Mutation Report for Customer: f21c5b7c-d7e5-4fae-969c-5e
NutraHacker Detox and Methylation Mutation Report for Customer: f21c5b7c-d7e5-4fae-969c-5e6925488206 Instructions: This FREE NutraHacker report contains detox and methylation mutations (single nucleotide
More information